本页面由Tiger Trade Technology Pte. Ltd.提供服务

Exagen

3.70
+0.29008.50%
盘前3.700.00000.00%07:47 EST
成交量:62.56万
成交额:231.66万
市值:8,385.35万
市盈率:-3.94
高:3.83
开:3.42
低:3.20
收:3.41
52周最高:12.23
52周最低:2.67
股本:2,266.31万
流通股本:1,435.49万
量比:2.44
换手率:4.36%
股息:- -
股息率:- -
每股收益(TTM):-0.9394
每股收益(LYR):-0.8304
净资产收益率:-122.81%
总资产收益率:-14.66%
市净率:4.62
市盈率(LYR):-4.46

数据加载中...

公司资料

公司名字:
Exagen
交易所:
NASDAQ
成立时间:
2002
员工人数:
212
公司地址:
1261 Liberty Way,Suite C,Vista,California,United States
邮编:
92081
电话:
传真:
- -
简介:
Exagen Inc.成立于2002年。Exagen致力于通过及时鉴别诊断和优化治疗干预,改变患有衰弱和慢性自身免疫疾病的患者的护理连续体。该公司的目标是通过鉴别诊断,预后和监测复杂的自身免疫和自身免疫相关疾病(包括SLE和类风湿性关节炎或RA),使风湿病学家能够改善对患者的护理。

董事

名称
职位
John Aballi
Director, President and Chief Executive Officer
Tina S. Nova
Executive Chairman of the Board
Ana Hooker
Independent Director
Bruce C. Robertson
Independent Director
Frank Stokes
Independent Director
Paul Kim
Independent Director
Scott D. Kahn
Independent Director
Charles S. McKhann
Director

股东

名称
职位
John Aballi
Director, President and Chief Executive Officer
Jeffrey G. Black
Chief Financial Officer; Principal Accounting Officer and Corporate Secretary
Tina S. Nova
Executive Chairman of the Board